Market Overview

UPDATE: Stifel Upgrades WebMD Health On Possible Upside

Share:

In a report published Wednesday, Stifel analyst Steven Rubis upgraded the rating on WebMD Health (NASDAQ: WBMD) from Hold to Buy, and named a $60.00 price target.

In the report, Stifel noted, “Our upgrade stems from strong industry macro trends and our view that current estimates for 3Q14 and 4Q14 advertising revenue growth are likely conservative. Previously, we estimated 8% y/y and 5% y/y advertising growth in 3Q14 and 4Q14, respectively, versus consensus growth of 10.3% y/y and 8.0% y/y, respectively. We now forecast 10% y/y advertising growth in both 3Q14 and 4Q14.

"Our current expectation is that 8% y/y advertising growth in 4Q14 will prove conservative should the company report a solid 2Q14 and 3Q14. We believe strong industry macro trends, as well as stability in WebMD specific ad trends, suggests the company will likely report solid 2Q14 results. We look to the company's 3Q14 guidance and possible upward revisions to FY14 guidance on its 2Q14 conference call as further support.”

WebMD Health closed on Tuesday at $49.85.

Latest Ratings for WBMD

DateFirmActionFromTo
Jul 2017DowngradesOutperformMarket Perform
Jul 2017DowngradesBuyHold
Mar 2017DowngradesOutperformMarket Perform

View More Analyst Ratings for WBMD
View the Latest Analyst Ratings

Posted-In: Steven Rubis StifelAnalyst Color Upgrades Analyst Ratings

 

Related Articles (WBMD)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
CAPRMaintains12.4
BCELInitiates Coverage On23.0
DNOWMaintains14.0
HLIOMaintains46.0
GDIMaintains33.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Canaccord Initiates Coverage On Solar City, Sees High Growth Potential

UPDATE: Stifel Upgrades The Men's Wearhouse As JOSB Acquisition Is Complete